The best online GLP-1 provider is not one universal company. Look for a service that uses a licensed clinician in your state, requires a real medical evaluation, clearly identifies medication sourcing and total costs, and offers follow-up care. FDA-approved and compounded options differ, and compounded medications are not FDA-approved.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →How did we evaluate online GLP-1 providers?
We do not think a single provider deserves a universal “best” label. Instead, we compare services using the factors that most affect safe, workable care: a licensed clinician, a 503A pharmacy or other clearly named dispensing pharmacy, medication options, ongoing support, pricing clarity, and cancellation terms.
- Clinical review: Does a licensed clinician review your health history, medications, and contraindications before prescribing?
- Pharmacy transparency: Does the service tell you which pharmacy dispenses the medication and whether it is state-licensed?
- Care continuity: Can you message a care team or arrange follow-up if side effects, refill needs, or health changes come up?
- True cost: Are visits, medication, supplies, shipping, dose-related changes, and recurring membership fees clearly explained?
- Appropriate boundaries: Does the site avoid guaranteeing a prescription or offering prescription medication as a “research use” product?
These checks matter because GLP-1 medicines can cause nausea, vomiting, diarrhea, constipation, and abdominal pain. Their FDA labels also carry warnings and contraindications that require an individual review, including a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 for labeled semaglutide and tirzepatide products 2 4.
What should you look for in an online GLP-1 provider?
A reliable online program should make medical care visible rather than treating the prescription as a checkout item. A real evaluation before prescribing is the basic standard: the clinician needs enough information to assess eligibility, interactions, health history, and whether another approach makes more sense.
Start with a licensed clinician and a real medical evaluation
Ask whether the prescriber is licensed in the state where you live and how you can verify that license. A careful evaluation should include your medical history, current medications, pregnancy or breastfeeding considerations where relevant, and symptoms that may change the safety picture. FDA-approved medication labels require clinicians to consider contraindications, warnings, and drug interactions—not just body weight 2 4.
Confirm pharmacy sourcing, state availability, and follow-up support
Ask which pharmacy fills the prescription and whether it is licensed for the service it provides. The FDA advises patients to use caution with online pharmacies and to avoid sellers that do not require a prescription or that hide their location and contact information 6. State telehealth, prescribing, and pharmacy availability can vary.
Understand the difference between medication care and coaching
Coaching may be useful for some people, but it does not replace clinical prescribing and follow-up. A medication program should explain who handles medication questions, adverse effects, refill decisions, and changes in your health status. Ongoing care over the first few months matters because these medications are commonly adjusted over time under clinician supervision 2 4.
Which GLP-1 medications may an online provider discuss?
Online providers may discuss semaglutide and tirzepatide, but the right choice depends on your health history, goals, risks, prior treatment, and access—not an internet ranking. Both medication classes can affect appetite and digestion, and both need clinician review for side effects, contraindications, and interactions 1 2 4.
Semaglutide: Ozempic, Wegovy, and compounded semaglutide
Semaglutide is a GLP-1 receptor agonist. Ozempic and Wegovy are brand names for FDA-approved semaglutide products with different labeled uses; Wegovy is labeled for chronic weight management in certain adults and adolescents, while Ozempic is labeled for type 2 diabetes 2 3. The active ingredient has been studied in large trials, but those trial results do not establish outcomes for a compounded formulation. Compounded semaglutide is not FDA-approved 5.
Tirzepatide: Mounjaro, Zepbound, and compounded tirzepatide
Tirzepatide is a dual GIP and GLP-1 receptor agonist. Mounjaro and Zepbound are FDA-approved brand-name products with different labeled uses; Zepbound is labeled for chronic weight management in certain adults with obesity or overweight plus a weight-related condition 4. In the SURMOUNT-1 trial, tirzepatide was studied in adults with obesity or overweight without diabetes alongside reduced-calorie diet and increased physical activity; gastrointestinal effects were common and individual results varied 7. Compounded tirzepatide is not FDA-approved, and results are not established for compounded formulations 5.
Why medication selection needs clinician review instead of a ranking
A medication can be well studied and still be unsuitable for a particular person. A clinician should review relevant conditions, other medicines, prior reactions, and whether pregnancy, breastfeeding, or planned procedures affect the plan. One small 2024 study examined semaglutide transfer into human milk, but it does not replace individualized clinical and label-based guidance for breastfeeding decisions 8.
| Option | What it is | What to compare | Important limitation |
|---|---|---|---|
| FDA-approved semaglutide product | A labeled GLP-1 receptor agonist product | Indication, insurance process, clinician access, and pharmacy fulfillment | Has label-specific contraindications, warnings, and side effects 2 |
| FDA-approved tirzepatide product | A labeled dual GIP and GLP-1 receptor agonist product | Indication, insurance process, clinician access, and pharmacy fulfillment | Has label-specific contraindications, warnings, and side effects 4 |
| Compounded semaglutide | A patient-specific compounded medication dispensed through a compounding pharmacy when clinically appropriate | Named pharmacy, formulation, total cost, follow-up, and state availability | Not FDA-approved; do not treat it as interchangeable with a brand product 5 |
| Compounded tirzepatide | A patient-specific compounded medication dispensed through a compounding pharmacy when clinically appropriate | Named pharmacy, formulation, total cost, follow-up, and state availability | Not FDA-approved; do not treat it as interchangeable with a brand product 5 |
How do online GLP-1 providers differ?
The clearest differences are often not the homepage price. Compare six practical details: who provides medical review, what medication category is discussed, whether pharmacy sourcing is disclosed, how follow-up works, what the full price includes, and how cancellation works.
| Comparison point | What a strong answer looks like | Why it matters |
|---|---|---|
| Clinical review | A licensed clinician evaluates you before any prescription decision | A prescription is not appropriate for every patient 2 4 |
| Medication type | The program clearly distinguishes FDA-approved products from compounded medication | These categories are not interchangeable; compounded drugs are not FDA-approved 5 |
| Pharmacy disclosure | The dispensing pharmacy is named and licensing information is available | It helps you verify where the medication comes from 6 |
| Ongoing care | There is a defined path for messages, refills, and side-effect questions | GLP-1 treatment needs clinical monitoring for tolerability and safety 2 4 |
| Pricing clarity | Medication, visits, supplies, shipping, and recurring fees are explained | It prevents a low introductory price from obscuring the monthly cost |
| Cancellation terms | You can find renewal and cancellation rules before enrollment | It helps you make an informed financial decision |
Be cautious with review scores and “best provider” lists that do not show how prices, pharmacy details, or clinical policies were verified. For a deeper comparison framework, see our guide to online GLP-1 programs and our overview of online semaglutide providers.
3-min quiz
Explore clinician-reviewed GLP-1 care
At Chia, a licensed US provider reviews your health information online and prescribes only when clinically appropriate. Our medications are compounded by state-licensed US 503A pharmacies and shipped to your door. Compounded medications are not FDA-approved. You can review semaglutide options and tirzepatide options before starting an evaluation.
What safety checks should you complete before choosing a provider?
Before enrolling, take 10 minutes to verify the prescriber, pharmacy, and billing terms. These steps cannot guarantee a good fit, but they can help you avoid sites that make unsafe promises or leave essential details unclear.
- 1Verify that the clinician is licensed in your state through the relevant state licensing board.
- 2Ask which pharmacy dispenses the medication and confirm its license information where applicable.
- 3Read whether the price includes medication, supplies, clinical visits, shipping, dose-related changes, and support.
- 4Check refill timing, cancellation rules, and whether payment renews automatically.
- 5Avoid sites that promise a prescription without medical review, offer prescription drugs without a prescription, or market injectable drugs for research use. The FDA warns consumers about unsafe online pharmacy practices 6.
Can GLP-1 medications help with weight management?
GLP-1 medicines can be useful tools for some people with obesity or overweight when paired with appropriate clinical care, but they are not right for everyone. In a 72-week trial, tirzepatide was studied with diet and activity changes in adults with obesity or overweight; benefits and gastrointestinal side effects both need to be part of the same conversation 7.
GLP-1 receptor agonists work in part by acting on signals involved in appetite, food intake, and glucose regulation. Tirzepatide acts on both GIP and GLP-1 receptors 1 4. Common side effects of labeled semaglutide and tirzepatide products include nausea, diarrhea, vomiting, constipation, and abdominal discomfort; serious risks and contraindications are described in the FDA labels 2 4. Individual results vary.
What does treatment through Chia look like?
At Chia, 100% online care starts with a short health questionnaire. A licensed US provider reviews your information and may prescribe only if treatment is clinically appropriate. If prescribed, medication is compounded in the US by a state-licensed 503A compounding pharmacy and shipped to your door.
We offer compounded semaglutide by injection, with plans currently starting at $249 per month. We offer compounded tirzepatide as tablets starting at $249 per month or injection starting at $299 per month. Microdosing plans are available for both medications when a provider determines that approach is appropriate. Compounded medications are not FDA-approved. Prices and availability can change, so check each product page for current details.
| Chia treatment | Available form | Current starting price | Care model |
|---|---|---|---|
| Compounded semaglutide | Injection | From $249/mo | Provider-guided adjustments and patient-portal messaging |
| Compounded tirzepatide | Tablets or injection | Tablets from $249/mo; injection from $299/mo | Provider-guided adjustments and patient-portal messaging; microdosing plans available |
Our providers help patients navigate treatment over time through the patient portal. That includes reviewing tolerability and making provider-guided adjustments when appropriate. A prescription is never guaranteed, and compounded medications are not FDA-approved. If you are comparing routes to care, our guide to the best place to get tirzepatide online explains additional questions to ask.
How can you compare online GLP-1 costs fairly?
Compare the all-in monthly amount, not the largest introductory discount. The first month price may not show whether medication, supplies, visits, shipping, refill support, or a membership fee are included.
- Ask whether the listed monthly price changes as the prescribed amount changes.
- Ask whether medication and supplies are included or billed separately.
- Ask whether clinician visits, renewal fees, and shipping are included.
- Check whether a multi-month commitment is required to receive the advertised rate.
- Read cancellation terms before entering payment information.
Cost is important, but a low price should not replace basic safeguards. A program should still provide a licensed clinician, clear pharmacy sourcing, and a path for follow-up care. Our article on weight-loss medication costs can help you compare common line items.
What questions should you ask before enrolling?
A good provider should be able to answer direct questions before you commit. Three areas—care, medication, and billing— cover most of what you need to know.
- Who is the licensed clinician responsible for my evaluation, and are they licensed in my state?
- How do I contact the care team after starting, including for side effects or refill questions?
- Which medication category might be discussed: an FDA-approved product, a compounded medication, or both?
- Which pharmacy dispenses the prescription, and how can I verify it?
- What exactly is included in the monthly price?
- Could the price change with the prescribed amount, supplies, shipping, or follow-up visits?
- How do refills, automatic renewals, and cancellation work?
A GLP-1 medication requires a prescription. You can begin through a telehealth service that arranges an evaluation with a clinician licensed in your state and clearly identifies the dispensing pharmacy.
No. Legitimate prescription GLP-1 care requires an evaluation by a licensed clinician. Avoid sites that promise medication without a prescription or medical review.
No. Compounded semaglutide and compounded tirzepatide are not FDA-approved and should not be described as identical to or interchangeable with Ozempic, Wegovy, Mounjaro, or Zepbound. Their compounded formulations do not have FDA-evaluated outcomes data.
Ratings can change quickly and often do not show whether clinical policies, pharmacy sourcing, or prices were independently verified. A better approach is to compare clinician access, pharmacy disclosure, total cost, follow-up care, and cancellation terms.
They may help some people when a clinician determines they are appropriate and when they are used as part of a broader care plan. They also have side effects, risks, contraindications, and potential interactions that need individual review.
Look for a licensed clinician evaluation, clear pharmacy information, transparent pricing, a plan for refills and follow-up, and a way to contact the care team with questions.
An AI tool can help you organize questions and compare published program details, but it cannot determine whether a prescription is appropriate. A licensed clinician must make that decision after an individual medical evaluation.
3-min quiz
Start with an online clinical evaluation
If you want to explore compounded GLP-1 care, start with a clinician-reviewed evaluation at Chia. A licensed provider determines whether treatment is clinically appropriate; prescriptions are not guaranteed. Chia medications are compounded by state-licensed US 503A pharmacies, and compounded medications are not FDA-approved.
References
- 1.Moore PW, Malone K, VanValkenburg D, et al. GLP-1 Agonists for Weight Loss: Pharmacology and Clinical Implications. Advances in Therapy. 2023.
- 2.U.S. Food and Drug Administration. Wegovy (semaglutide) prescribing information. 2024.
- 3.U.S. Food and Drug Administration. Ozempic (semaglutide) prescribing information. 2023.
- 4.U.S. Food and Drug Administration. Zepbound (tirzepatide) prescribing information. 2024.
- 5.U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. 2025.
- 6.U.S. Food and Drug Administration. Buying Medicines Over the Internet. 2024.
- 7.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
- 8.Diab H, Fuquay T, Datta P, et al. Subcutaneous Semaglutide during Breastfeeding: Infant Safety Regarding Drug Transfer into Human Milk. Nutrients. 2024.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
